TPG Cap to acquire majority stake in DOC Generici from ICG and Merieux Equity Partners

TPG Capital, the private equity platform of global alternative asset management firm TPG, is to acquire a majority interest in DOC Generici, a manufacturer of generic pharmaceuticals in Italy, from ICG and Merieux Equity Partners.

As part of the transaction, Karthic Jayaraman, Partner at TPG Capital, and TPG Capital Principal Ravi Umarji will join DOC Generici’s Board of Directors.

Mediobanca, Morgan Stanley & Co International plc, and Deutsche Bank acted as financial advisors to TPG Capital, and Latham & Watkins served as legal counsel. Barclay’s and BNP served as financial advisors to DOC Generici, and Gattai served as legal counsel.

Get the week’s top news delivered directly to your inbox – Sign up for our newsletter

Sign up

TPG is a leading global alternative asset management firm founded in San Francisco in 1992 with $109 billion of assets under management and investment and operational teams in 12 offices globally.

TPG invests across five multi-product platforms: Capital, Growth, Impact, Real Estate, and Market Solutions and our unique strategy is driven by collaboration, innovation, and inclusion. Our teams combine deep product and sector experience with broad capabilities and expertise to develop differentiated insights and add value for our fund investors, portfolio companies, management teams, and communities.

Source: Laing Buisson

Can’t stop reading? Read more